Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 205,629,573 papers from all fields of science
Search
Sign In
Create Free Account
TOBI Podhaler 224 Capsule Monthly Pack
Known as:
TOBRAMYCIN 28 mg RESPIRATORY (INHALATION) CAPSULE [TOBI Podhaler]_#1
, {224 (Tobramycin 28 MG Inhalant Powder [Tobi]) } Pack [TOBI Podhaler Kit]
, TOBI Podhaler Kit, 4 Weekly Packs, each including 56 capsules (7 Blister Cards of 8 Capsules)
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
7 relations
1,2-distearoyllecithin
Calcium Chloride
Pack
Sulfuric acid
Expand
Broader (2)
Tobramycin 28 MG Inhalant Powder [Tobi]
{224 (Tobramycin 28 MG Inhalant Powder) } Pack
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Treatment compliance in cystic fibrosis patients with chronic Pseudomonas aeruginosa infection treated with tobramycin inhalation powder: The FREE study.
F. Blasi
,
V. Carnovale
,
+6 authors
P. Porpiglia
Respiratory medicine
2018
Corpus ID: 19219710
2017
2017
Physical Characterization of Tobramycin Inhalation Powder: II. State Diagram of an Amorphous Engineered Particle Formulation.
Danforth P Miller
,
Trixie Tan
,
J. Nakamura
,
R. Malcolmson
,
T. Tarara
,
J. Weers
Molecular pharmaceutics
2017
Corpus ID: 3977333
Tobramycin Inhalation Powder (TIP) is a spray-dried engineered particle formulation used in TOBI Podhaler, a drug-device…
Expand
2016
2016
The development of a single-use, capsule-free multi-breath tobramycin dry powder inhaler for the treatment of cystic fibrosis.
Bing Zhu
,
Matteo Padroni
,
+4 authors
D. Traini
International journal of pharmaceutics
2016
Corpus ID: 30213592
2015
2015
ePS03.3 Longer term tolerance and likely adherence to TOBI Podhaler in CF adults
C. Brown
,
S. Cameron
,
+5 authors
E. Nash
2015
Corpus ID: 71069639
2014
2014
Population Pharmacokinetics of Inhaled Tobramycin Powder in Cystic Fibrosis Patients
L. Ting
,
S. Aksenov
,
S. Bhansali
,
R. Ramakrishna
,
P. Tang
,
D. Geller
CPT: pharmacometrics & systems pharmacology
2014
Corpus ID: 16560232
Tobramycin powder for inhalation (TOBI Podhaler or TIP) is approved for the treatment of Pseudomonas aeruginosa airway infection…
Expand
Review
2013
Review
2013
Colistimethate sodium powder and tobramycin powder for inhalation for the treatment of chronic Pseudomonas aeruginosa lung infection in cystic fibrosis: systematic review and economic model.
P. Tappenden
,
S. Harnan
,
L. Uttley
,
M. Mildred
,
C. Carroll
,
A. Cantrell
Health technology assessment
2013
Corpus ID: 27438927
BACKGROUND Cystic fibrosis (CF) is an inherited condition characterised by the abnormal transport of chloride ions across…
Expand
Review
2013
Review
2013
[TOBI Podhaler for treating chronic Pseudomonas aeruginosa infection in cystic fibrosis patients].
F. Piérart
Revue medicale de Liege
2013
Corpus ID: 28916625
TOBI Podhaler is the first dry powder formulation of tobramycin for inhaled therapy of chronic Pseudomonas aeruginosa infection…
Expand
Highly Cited
2011
Highly Cited
2011
Safety, efficacy and convenience of tobramycin inhalation powder in cystic fibrosis patients: The EAGER trial.
M. Konstan
,
P. Flume
,
+7 authors
D. Geller
Journal of cystic fibrosis : official journal of…
2011
Corpus ID: 5805169
Review
2011
Review
2011
Tobramycin administered by the TOBI® Podhaler® for persons with cystic fibrosis: a review
D. VanDevanter
,
D. Geller
Medical devices
2011
Corpus ID: 8160980
From its introduction, the antibiotic tobramycin has been an important tool in the management of persons with cystic fibrosis (CF…
Expand
2008
2008
Impacto clínico y evolución microbiológica tras tratamiento con tobramicina inhalada en bronquiectasias colonizadas por Pseudomonas aeruginosa.
B. Bueno
,
J. Barrios
,
F. Luna
,
María Jesús Cobos Ceballos
,
M. Marín
,
L. M. Cabrera
2008
Corpus ID: 70524515
espanolFUNDAMENTO: Evaluar la eficacia de tobramicina nebulizada �TOBI®� en la modificacion de la historia natural de la…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
,
Terms of Service
, and
Dataset License
ACCEPT & CONTINUE